N
SWTX

Natixis’s SpringWorks Therapeutics SWTX Stock Holding History

Natixis’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-63,800
Closed -$2.33M – 1223
2023
Q4 		$2.33M Buy
+63,800
New +$1.67M 0.02% 394
2022
Q2 		– Sell
-95,000
Closed -$5.36M – 1356
2022
Q1 		$5.36M Buy
+95,000
New +$5.44M 0.02% 537
2021
Q4 		– Sell
-33,400
Closed -$2.12M – 1350
2021
Q3 		$2.12M Buy
+33,400
New +$2.57M 0.01% 715
2021
Q2 		– Sell
-35,800
Closed -$2.63M – 1013
2021
Q1 		$2.63M Sell
35,800
-30,600
-46% -$2.4M 0.01% 632
2020
Q4 		$4.82M Buy
+66,400
New +$4.27M 0.02% 519

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return